{"acute leukaemia": 16.15, "acute myeloid leukaemia": 28.7, "adverse drug reaction": 2.42, "anaemia": 44.0, "ascites": 5.13, "blood creatinine increased": 3.37, "blood test abnormal": 3.64, "carbohydrate antigen 125 increased": 365.49, "creatinine renal clearance decreased": 4.92, "decreased appetite": 2.57, "disease progression": 3.62, "disease recurrence": 2.03, "drug intolerance": 2.61, "dyspepsia": 2.27, "erythema nodosum": 4.25, "feeding disorder": 2.55, "full blood count abnormal": 3.97, "gastrointestinal disorder": 2.19, "glomerular filtration rate decreased": 3.81, "haematocrit decreased": 2.14, "haematotoxicity": 24.09, "haemoglobin decreased": 9.27, "hypophagia": 2.0, "ileus": 15.68, "interstitial lung disease": 8.79, "intestinal obstruction": 4.41, "laboratory test abnormal": 3.06, "leukaemia": 6.56, "leukopenia": 2.95, "maligt neoplasm progression": 22.55, "metastases to bone": 7.66, "metastases to central nervous system": 16.7, "metastases to liver": 7.94, "metastases to lung": 4.37, "metastases to lymph nodes": 13.55, "metastases to meninges": 11.94, "metastases to peritoneum": 41.84, "metastasis": 23.39, "myelodysplastic syndrome": 74.15, "myelosuppression": 5.29, "nausea": 2.56, "neoplasm": 4.54, "neutropenia": 4.07, "neutrophil count decreased": 18.74, "no adverse event": 5.54, "off label use": 3.16, "ovarian cancer": 5.04, "ovarian cancer recurrent": 1037.79, "pancytopenia": 5.96, "platelet count decreased": 9.06, "pneumocystis jirovecii pneumonia": 3.87, "pneumonitis": 4.97, "product dose omission issue": 2.15, "product use complaint": 5.14, "product use in unapproved indication": 2.44, "product use issue": 2.28, "prostatic specific antigen increased": 11.2, "recurrent cancer": 36.2, "red blood cell count decreased": 6.28, "renal impairment": 3.45, "stomatitis": 2.74, "taste disorder": 6.5, "thrombocytopenia": 5.26, "tumour marker increased": 55.58, "white blood cell count decreased": 4.38}